How the tumor microenvironment contributes to drug-resistant neuroblastoma
5/15/2015
Researchers at Children's Hospital Los Angeles have made an important step toward finding a target in the fight against drug-resistant neuroblastoma (NBL), the most common solid malignancy found...
Fracking may affect air quality and human health
5/15/2015
People living or working near active natural gas wells may be exposed to certain pollutants at higher levels than the Environmental Protection Agency considers safe for lifetime exposure, according...
Anemia distorts regular method of diabetes diagnosis and questions its reliability
5/15/2015
The use of glycated haemoglobin (sugar-bound haemoglobin, or HbA1c) is now in almost universal use to assist doctors in the diagnosis of type 2 diabetes.
CNIO scientists are able to take immortality from cancer
5/15/2015
Scientists from the Spanish National Cancer Research Centre (CNIO) have discovered a new strategy to fight cancer, which is very different from those described to date.
Survival from rare bone cancer remains low
5/15/2015
But mesenchymal chondrosarcoma not as deadly as previously reported, study findsAmong the deadliest cancers is a rare malignancy called mesenchymal chondrosarcoma, which begins in cartilage...
Researcher discovers molecules that could kill cancer while protecting healthy cells
5/15/2015
Researchers have identified new molecules that kill cancer cells while protecting healthy cells and that could be used to treat a variety of different cancers.
Inconsistent Medicaid expansion would widen disparities in screenings for women's cancers
5/15/2015
Massey researchers find that failure to expand ACA Medicaid coverage would widen disparities in screening uninsured and low-income women for breast and cervical cancerVirginia Commonwealth...
siRNA-toting nanoparticles inhibit breast cancer metastasis
5/15/2015
Researchers at Case Western Reserve University combined finely crafted nanoparticles with one of nature's potent disrupters to prevent the spread of triple-negative breast cancer in mouse models.
Invectys initiates Phase I clinical trial evaluating INVAC-1 therapeutic vaccine for cancer patients
5/14/2015
Invectys has announced that it has initiated a phase I clinical trial of its immunotherapeutic drug candidate INVAC-1.
Contraceptive and cholesterol-lowering drugs used to treat cancer
5/14/2015
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers...